Two genetic pathways for age-related macular degeneration

Current Opinion in Genetics and Development

Volumn 17, Issue 3, 2007, Pages 228-233

  DeWan, Andrew ^a   Bracken, Michael B ^a   Hoh, Josephine ^a  

^a YALE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALTERNATIVE COMPLEMENT PATHWAY C3 C5 CONVERTASE; C REACTIVE PROTEIN; COMPLEMENT FACTOR H; HTRA SERINE PEPTIDASE 1; PEPTIDASE; SERINE PROTEINASE; UNCLASSIFIED DRUG;

GENE FREQUENCY; HIGH RISK POPULATION; HUMAN; PATHOPHYSIOLOGY; PHENOTYPE; PRIORITY JOURNAL; RETINA MACULA AGE RELATED DEGENERATION; REVIEW; RISK ASSESSMENT;

AGE OF ONSET; C-REACTIVE PROTEIN; COMPLEMENT SYSTEM PROTEINS; HUMANS; MACULAR DEGENERATION; SERINE ENDOPEPTIDASES; SIGNAL TRANSDUCTION;

EID: 34249675827     PISSN: 0959437X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.gde.2007.04.004     Document Type: Review

References (46)

1. ••], this paper describes an extremely important advance in the area of AMD treatment that uses antibodies to vascular endothelial growth factor to inhibit neovascularization. Unfortunately, space considerations have not permitted an in-depth discussion of AMD treatment in this review, but readers should be aware of this groundbreaking therapy.
2. ••].
3. The News Staff. Breakthrough of the year. The Runners-Up. Science 314 (2006) 1850-1855
4. •] of AMD from the molecular to the clinical level serve as excellent primers to this disease and are two of the best to date. They highlight the complex pathophysiology that leads to this heterogeneous disease.
5. ••].
6. Dewan A., Liu M., Hartman S., Zhang S.S., Liu D.T., Zhao C., Tam P.O., Chan W.M., Lam D.S., Snyder M., et al. HTRA1 promoter polymorphism in wet age-related macular degeneration. Science 314 (2006) 989-992. This paper identifies a potential functional mutation associated with AMD in the 10q26 linkage region by abandoning the conventional wisdom that the functional mutation is located in the hypothetical gene LOC38715. The authors show that there is little homology across species at the hypothetical locus and identify an polymorphism in the HTRA1 promoter through exhaustive sequencing of the region.
7. Fisher S.A., Abecasis G.R., Yashar B.M., Zareparsi S., Swaroop A., Iyengar S.K., Klein B.E., Klein R., Lee K.E., Majewski J., et al. Meta-analysis of genome scans of age-related macular degeneration. Hum Mol Genet 14 (2005) 2257-2264. The authors compile a mountain of genetic data that has been collected over the past decade or so and perform a meta-analysis to identify the most promising regions for AMD susceptibility loci. Two of these 'top' regions have subsequently had functional variants localized within them - a testament to the thorough analysis presented in this paper.
8. Klein R.J., Zeiss C., Chew E.Y., Tsai J.Y., Sackler R.S., Haynes C., Henning A.K., Sangiovanni J.P., Mane S.M., Mayne S.T., et al. Complement factor H polymorphism in age-related macular degeneration. Science 308 (2005) 385-389. This paper represents one of the first successful whole-genome association studies and is the first to identify a functional variant related to AMD. The authors present both the SNP association study and functional data to support the evidence that a coding polymorphism is the variant of interest.
9. Haines J.L., Hauser M.A., Schmidt S., Scott W.K., Olson L.M., Gallins P., Spencer K.L., Kwan S.Y., Noureddine M., Gilbert J.R., et al. Complement factor H variant increases the risk of age-related macular degeneration. Science 308 (2005) 419-421
10. Edwards A.O., Ritter III R., Abel K.J., Manning A., Panhuysen C., and Farrer L.A. Complement factor H polymorphism and age-related macular degeneration. Science 308 (2005) 421-424
11. Hageman G.S., Anderson D.H., Johnson L.V., Hancox L.S., Taiber A.J., Hardisty L.I., Hageman J.L., Stockman H.A., Borchardt J.D., Gehrs K.M., et al. A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration. Proc Natl Acad Sci USA 102 (2005) 7227-7232
12. Haddad S., Chen C.A., Santangelo S.L., and Seddon J.M. The genetics of age-related macular degeneration: a review of progress to date. Surv Ophthalmol 51 (2006) 316-363
13. Hageman G.S., Luthert P.J., Victor Chong N.H., Johnson L.V., Anderson D.H., and Mullins R.F. An integrated hypothesis that considers drusen as biomarkers of immune-mediated processes at the RPE-Bruch's membrane interface in aging and age-related macular degeneration. Prog Retin Eye Res 20 (2001) 705-732
14. Alexander J.J., and Quigg R.J. The simple design of complement factor H: Looks can be deceiving. Mol Immunol 44 (2007) 123-132
15. Johnson L.V., Leitner W.P., Staples M.K., and Anderson D.H. Complement activation and inflammatory processes in drusen formation and age related macular degeneration. Exp Eye Res 73 (2001) 887-896
16. Schlaf G., Nitzki F., Heine I., Hardeland R., Schieferdecker H.L., and Gotze O. C5a anaphylatoxin as a product of complement activation up-regulates the complement inhibitory factor H in rat Kupffer cells. Eur J Immunol 34 (2004) 3257-3266
17. Rodriguez de Cordoba S., Esparza-Gordillo J., Goicoechea de Jorge E., Lopez-Trascasa M., and Sanchez-Corral P. The human complement factor H: functional roles, genetic variations and disease associations. Mol Immunol 41 (2004) 355-367
18. Hughes A.E., Orr N., Esfandiary H., Diaz-Torres M., Goodship T., and Chakravarthy U. A common CFH haplotype, with deletion of CFHR1 and CFHR3, is associated with lower risk of age-related macular degeneration. Nat Genet 38 (2006) 1173-1177. Exploring the CFH gene cluster further, the authors identify a haplotype containing a deletion of two CFH-related genes that decreases the risk of developing AMD. This deletion has implications not only for AMD susceptibility, but also gives insight into how the alternative complement pathway might be regulated by suggesting that the CFH-related proteins interfere with CFH binding to C3b.
19. Magnusson K.P., Duan S., Sigurdsson H., Petursson H., Yang Z., Zhao Y., Bernstein P.S., Ge J., Jonasson F., Stefansson E., et al. CFH Y402H confers similar risk of soft drusen and both forms of advanced AMD. PLoS Med 3 (2006) e5
20. Gotoh N., Yamada R., Hiratani H., Renault V., Kuroiwa S., Monet M., Toyoda S., Chida S., Mandai M., Otani A., et al. No association between complement factor H gene polymorphism and exudative age-related macular degeneration in Japanese. Hum Genet 120 (2006) 139-143
21. Okamoto H., Umeda S., Obazawa M., Minami M., Noda T., Mizota A., Honda M., Tanaka M., Koyama R., Takagi I., et al. Complement factor H polymorphisms in Japanese population with age-related macular degeneration. Mol Vis 12 (2006) 156-158
22. Grassi M.A., Fingert J.H., Scheetz T.E., Roos B.R., Ritch R., West S.K., Kawase K., Shire A.M., Mullins R.F., and Stone E.M. Ethnic variation in AMD-associated complement factor H polymorphism p.Tyr402His. Hum Mutat 27 (2006) 921-925
23. Sandberg M.A., Weiner A., Miller S., and Gaudio A.R. High-risk characteristics of fellow eyes of patients with unilateral neovascular age-related macular degeneration. Ophthalmology 105 (1998) 441-447
24. Uyama M., Takahashi K., Ida N., Miyashiro M., Ando A., Takahashi A., Yamada E., Shirasu J., Nagai Y., and Takeuchi M. The second eye of Japanese patients with unilateral exudative age related macular degeneration. Br J Ophthalmol 84 (2000) 1018-1023
25. Yuzawa M., Hagita K., Egawa T., Minato H., and Matsui M. Macular lesions predisposing to senile disciform macular degeneration. Jpn J Ophthalmol 35 (1991) 87-95
26. Gold B., Merriam J.E., Zernant J., Hancox L.S., Taiber A.J., Gehrs K., Cramer K., Neel J., Bergeron J., Barile G.R., et al. Variation in factor B (BF) and complement component 2 (C2) genes is associated with age-related macular degeneration. Nat Genet 38 (2006) 458-462. This paper solidifies the hypothesis that it is the alternative complement pathway that is most important in the pathogenesis of AMD. It highlights the notion that all components of the complement pathway must be screened for variants related to AMD.
27. Regueiro J.R., and Arnaiz-Villena A. Human MHC class III (Bf, C2, C4) genes and GLO: their association with other HLA antigens and extended haplotypes in the Spanish population. Tissue Antigens 31 (1988) 14-25
28. Seddon J.M., George S., Rosner B., and Rifai N. Progression of age-related macular degeneration: prospective assessment of C-reactive protein, interleukin 6, and other cardiovascular biomarkers. Arch Ophthalmol 123 (2005) 774-782
29. Klein R., Klein B.E., Knudtson M.D., Wong T.Y., Shankar A., and Tsai M.Y. Systemic markers of inflammation, endothelial dysfunction, and age-related maculopathy. Am J Ophthalmol 140 (2005) 35-44
30. Donaldson M.J., and Pulido J.S. Treatment of nonexudative (dry) age-related macular degeneration. Curr Opin Ophthalmol 17 (2006) 267-274
31. Kardys I., Klaver C.C., Despriet D.D., Bergen A.A., Uitterlinden A.G., Hofman A., Oostra B.A., Van Duijn C.M., de Jong P.T., and Witteman J.C. A common polymorphism in the complement factor H gene is associated with increased risk of myocardial infarction: the Rotterdam Study. J Am Coll Cardiol 47 (2006) 1568-1575
32. McGwin Jr. G., Modjarrad K., Hall T.A., Xie A., and Owsley C. 3-Hydroxy-3-methylglutaryl coenzyme a reductase inhibitors and the presence of age-related macular degeneration in the Cardiovascular Health Study. Arch Ophthalmol 124 (2006) 33-37
33. Johnson P.T., Betts K.E., Radeke M.J., Hageman G.S., Anderson D.H., and Johnson L.V. Individuals homozygous for the age-related macular degeneration risk-conferring variant of complement factor H have elevated levels of CRP in the choroids. Proc Natl Acad Sci USA 103 (2006) 17456-17461. This is the first paper to provide a functional link between increased CRP and the CFH Y402H variant, supporting the idea that CRP has a role in AMD pathogenesis.
34. Schaumberg D.A., Christen W.G., Kozlowski P., Miller D.T., Ridker P.M., and Zee R.Y. A prospective assessment of the Y402H variant in complement factor H, genetic variants in C-reactive protein, and risk of age-related macular degeneration. Invest Ophthalmol Vis Sci 47 (2006) 2336-2340
35. Rivera A., Fisher S.A., Fritsche L.G., Keilhauer C.N., Lichtner P., Meitinger T., and Weber B.H. Hypothetical LOC387715 is a second major susceptibility gene for age-related macular degeneration, contributing independently of complement factor H to disease risk. Hum Mol Genet 14 (2005) 3227-3236
36. Jakobsdottir J., Conley Y.P., Weeks D.E., Mah T.S., Ferrell R.E., and Gorin M.B. Susceptibility genes for age-related maculopathy on chromosome 10q26. Am J Hum Genet 77 (2005) 389-407
37. Schmidt S., Hauser M.A., Scott W.K., Postel E.A., Agarwal A., Gallins P., Wong F., Chen Y.S., Spencer K., Schnetz-Boutaud N., et al. Cigarette smoking strongly modifies the association of LOC387715 and age-related macular degeneration. Am J Hum Genet 78 (2006) 852-864
38. Yang Z., Camp N.J., Sun H., Tong Z., Gibbs D., Cameron D.J., Chen H., Zhao Y., Pearson E., Li X., et al. A variant of the HTRA1 gene increases susceptibility to age-related macular degeneration. Science 314 (2006) 992-993. Not only does this paper replicate the association of an HTRA1 promoter polymorphism with AMD in a separate population, but it presents significant functional evidence that the promoter SNP results in an increase in HTRA1 expression in the retinas of individuals affected with AMD.
39. Oka C., Tsujimoto R., Kajikawa M., Koshiba-Takeuchi K., Ina J., Yano M., Tsuchiya A., Ueta Y., Soma A., Kanda H., et al. HtrA1 serine protease inhibits signaling mediated by TGFβ family proteins. Development 131 (2004) 1041-1053
40. Tocharus J., Tsuchiya A., Kajikawa M., Ueta Y., Oka C., and Kawaichi M. Developmentally regulated expression of mouse HtrA3 and its role as an inhibitor of TGF-β signaling. Dev Growth Differ 46 (2004) 257-274
41. AREDS Research Group. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, β carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. Arch Ophthalmol 119 (2001) 1417-1436
42. Muller-Eberhard H.J., Nilsson U., and Aronsson T. Isolation and characterization of two β1-glycoproteins of human serum. J Exp Med 111 (1960) 201-215
43. Pangburn M.K., Schreiber R.D., and Muller-Eberhard H.J. Formation of the initial C3 convertase of the alternative complement pathway. Acquisition of C3b-like activities by spontaneous hydrolysis of the putative thioester in native C3. J Exp Med 154 (1981) 856-867
44. Abdul Ajees A., Gunasekaran K., Volanakis J.E., Narayana S.V., Kotwal G.J., and Murthy H.M. The structure of complement C3b provides insights into complement activation and regulation. Nature 444 (2006) 221-225
45. Janssen B.J., Christodoulidou A., McCarthy A., Lambris J.D., and Gros P. Structure of C3b reveals conformational changes that underlie complement activity. Nature 444 (2006) 213-216
46. Wiesmann C., Katschke K.J., Yin J., Helmy K.Y., Steffek M., Fairbrother W.J., McCallum S.A., Embuscado L., DeForge L., Hass P.E., et al. Structure of C3b in complex with CRIg gives insights into regulation of complement activation. Nature 444 (2006) 217-220